Ruth Vera

2.8k total citations
102 papers, 1.8k citations indexed

About

Ruth Vera is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ruth Vera has authored 102 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 19 papers in Surgery. Recurrent topics in Ruth Vera's work include Colorectal Cancer Treatments and Studies (22 papers), Pancreatic and Hepatic Oncology Research (18 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Ruth Vera is often cited by papers focused on Colorectal Cancer Treatments and Studies (22 papers), Pancreatic and Hepatic Oncology Research (18 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Ruth Vera collaborates with scholars based in Spain, United States and United Kingdom. Ruth Vera's co-authors include Grazyna Kochan, Ana Bocanegra, Hugo Arasanz, Luisa Chocarro, David Escors, Ester Blanco, Miren Zuazo, Maider Garnica, Leticia Fernández and Miriam Echaide and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Ruth Vera

95 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Vera Spain 24 1.3k 394 357 347 283 102 1.8k
Hiroki Ochiai Japan 21 882 0.7× 408 1.0× 501 1.4× 365 1.1× 168 0.6× 61 1.7k
Aurélie Bertaut France 24 838 0.7× 590 1.5× 330 0.9× 303 0.9× 291 1.0× 105 1.8k
Wei Chua Australia 23 1.2k 0.9× 447 1.1× 348 1.0× 173 0.5× 512 1.8× 80 1.8k
Stefan Kasper Germany 24 885 0.7× 397 1.0× 268 0.8× 448 1.3× 190 0.7× 122 2.0k
Scott Ernst Canada 25 741 0.6× 659 1.7× 302 0.8× 159 0.5× 276 1.0× 55 1.8k
Andreas Trojan Switzerland 22 741 0.6× 295 0.7× 215 0.6× 567 1.6× 151 0.5× 64 1.8k
Aparna R. Parikh United States 22 1.5k 1.1× 625 1.6× 379 1.1× 214 0.6× 606 2.1× 162 2.1k
Miso Kim South Korea 25 1.2k 0.9× 710 1.8× 248 0.7× 276 0.8× 208 0.7× 87 1.7k
Jun‐Eul Hwang South Korea 25 663 0.5× 477 1.2× 580 1.6× 128 0.4× 262 0.9× 108 1.8k
Jae Ho Han South Korea 28 509 0.4× 383 1.0× 402 1.1× 299 0.9× 146 0.5× 88 1.5k

Countries citing papers authored by Ruth Vera

Since Specialization
Citations

This map shows the geographic impact of Ruth Vera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Vera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Vera more than expected).

Fields of papers citing papers by Ruth Vera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Vera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Vera. The network helps show where Ruth Vera may publish in the future.

Co-authorship network of co-authors of Ruth Vera

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Vera. A scholar is included among the top collaborators of Ruth Vera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Vera. Ruth Vera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Escors, David, Ana Bocanegra, Luisa Chocarro, et al.. (2022). Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy. International Journal of Molecular Sciences. 23(21). 13241–13241. 11 indexed citations
3.
Viúdez, A., Emilia Alors‐Pérez, Saioa Goñi, et al.. (2022). Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma. Cancers. 14(23). 5993–5993. 3 indexed citations
4.
Echaide, Miriam, Ibone Labiano, Ángela Fernández de Lascoiti, et al.. (2022). Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination. Cancers. 14(18). 4464–4464. 9 indexed citations
5.
Vidal, Joana, David Casadevall, Beatríz Bellosillo, et al.. (2021). Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial. Clinical Cancer Research. 27(10). 2890–2898. 62 indexed citations
6.
Arasanz, Hugo, Miren Zuazo, Ana Bocanegra, et al.. (2021). Hyperprogressive Disease: Main Features and Key Controversies. International Journal of Molecular Sciences. 22(7). 3736–3736. 20 indexed citations
7.
Alors‐Pérez, Emilia, Saioa Goñi, José C. Reyes, et al.. (2021). Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma. Frontiers in Medicine. 8. 720128–720128.
8.
Elez, Élena, Francisco Ayala, Enriqueta Felip, et al.. (2021). Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM). ESMO Open. 6(2). 100048–100048. 9 indexed citations
9.
Arasanz, Hugo, Carlos Hernández, Ana Bocanegra, et al.. (2020). Profound Reprogramming towards Stemness in Pancreatic Cancer Cells as Adaptation to AKT Inhibition. Cancers. 12(8). 2181–2181. 7 indexed citations
10.
Martín‐Pérez, Elena, J. Enrique Domínguez‐Muñoz, Francisco Botella Romero, et al.. (2020). Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer. Clinical & Translational Oncology. 22(11). 1963–1975. 29 indexed citations
11.
Arasanz, Hugo, Miren Zuazo, Ana Bocanegra, et al.. (2020). Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics. Cancers. 12(2). 344–344. 58 indexed citations
12.
Hernández, Carlos, Hugo Arasanz, Luisa Chocarro, et al.. (2020). Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies. International Journal of Molecular Sciences. 21(7). 2411–2411. 27 indexed citations
13.
Grande, Enrique, Àlex Teulé, Teresa Alonso‐Gordoa, et al.. (2020). The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407). The Oncologist. 25(9). 745–e1265. 24 indexed citations
14.
Grothey, Axel, Josep Tabernero, Julien Taı̈eb, et al.. (2020). LBA-5 ANCHOR CRC: a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer. Annals of Oncology. 31. S242–S243. 33 indexed citations
15.
Remón, Jordi, Rosario García‐Campelo, Enrique de Álava, et al.. (2019). Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Clinical & Translational Oncology. 22(6). 823–834. 23 indexed citations
16.
Garrido, Pilar, Azucena Aldaz, Miguel Ángel Calleja, et al.. (2017). Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH.. SHILAP Revista de lepidopterología. 41(6). 688–691. 4 indexed citations
17.
Vera, Ruth, Anne‐Marie Ferrandez, Mercè Marzo‐Castillejo, et al.. (2017). Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies. Clinical & Translational Oncology. 19(7). 834–843. 3 indexed citations
18.
Vera, Ruth, E. Dotor, Jaime Feliú, et al.. (2016). SEOM Clinical Guideline for the treatment of pancreatic cancer (2016). Clinical & Translational Oncology. 18(12). 1172–1178. 24 indexed citations
19.
Cabrera, Gonzalo & Ruth Vera. (2013). Consumo problemático de sustancias. 2 indexed citations
20.
Mesı́a, Ricard, A. Rueda, Ruth Vera, et al.. (2012). Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial. Annals of Oncology. 24(2). 448–453. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroki Ochiai Breakdown of academic impact, for papers by Aurélie Bertaut Breakdown of academic impact, for papers by Wei Chua Breakdown of academic impact, for papers by Stefan Kasper Breakdown of academic impact, for papers by Scott Ernst Breakdown of academic impact, for papers by Andreas Trojan Breakdown of academic impact, for papers by Aparna R. Parikh Breakdown of academic impact, for papers by Miso Kim Breakdown of academic impact, for papers by Jun‐Eul Hwang Breakdown of academic impact, for papers by Jae Ho Han
Rankless by CCL
2026